DRNA
Dicerna Pharmaceuticals Inc
Price:  
38.22 
USD
Volume:  
5,675,030.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DRNA Relative Valuation

-194.0%
Upside

As of 2025-07-11, the Relative Valuation of Dicerna Pharmaceuticals Inc (DRNA) is (35.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.22 USD, the upside of Dicerna Pharmaceuticals Inc based on Relative Valuation is -194.0%.

The range of the Relative Valuation is (29.21) - (40.15) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 16.2x - 24.4x 20.3x
Forward P/E multiples 17.8x - 29.1x 23.4x
Fair Price (29.21) - (40.15) (35.93)
Upside -176.4% - -205.0% -194.0%
38.22 USD
Stock Price
(35.93) USD
Fair Price

DRNA Relative Valuation - Historical P/E Data

Date P/E